The global non-invasive prenatal testing (NIPT) market is predicted to register huge growth in the coming years. The key factors driving the expansion of the market are the rising prevalence of chromosome syndrome, the increasing average maternal age in various countries, the surging expenditure being made in healthcare, and the rising demand for early fetal and non-invasive testing around the world. Chromosome syndromes such as Down syndrome and Edwards syndrome are caused because of genetic mutations in humans.
As per an article produced by the World Health Organization (WHO), around 3,000-5,000 infants all over the world are born with chromosome syndromes. Such high incidence of these diseases is pushing up the requirement for early and advanced prenatal testing, which is subsequently fueling the progress of the non-invasive prenatal testing market across the world. Besides this factor, the rising healthcare spending in many countries is also boosting the market advancement. 
As per the WHO, many countries are making huge investments in improving their healthcare infrastructure. This is propelling the affordability and accessibility of novel tests, which is, in turn, bosting the growing popularity of non-invasive prenatal testing procedures across the globe. When test type is taken into consideration, the non-invasive prenatal testing market is classified into NIFTY, Verifi, Panorama, MaterniT21 PLUS, PrenaTest, and Harmony. Amongst these, the MaterniT21 PLUS category recorded the highest growth in the market in the past. 
Moreover, this category is predicted to exhibit huge expansion in the market in the future years. On the other hand, the NIFTY category is predicted to demonstrate the fastest growth in the market in the forthcoming years. The biggest trend currently being witnessed in the non-invasive prenatal testing market is the rising strategic development activities like collaborations and partnerships being taken by various market players for ensuring faster availability, genetic solutions, and cost-effectiveness in order to support the education system.
The rising adaptability of non-invasive prenatal testing in developing countries is providing numerous growth opportunities for the players operating in the industry. The progress of the industry in these countries will be fueled by the rising average age and the increasing popularity of early fetal testing. Developing countries such as China and India large populations and are thus, augmenting their healthcare expenditure in order to make it advanced and suitable for proper healthcare. 
Globally, the market registered the highest growth in North America in the years gone by, as per the findings of P&S Intelligence, a market research firm based in India. The market growth was due to the high maternal age, huge healthcare spending, huge requirement for non-invasive procedures, and high prevalence of genetic syndromes in the region. In North America, the U.S. dominated the industry in the past and is predicted to hold a majority market share in the future years.
Hence, it can be said with surety that the market would demonstrate huge expansion all over the world in the coming years, mainly because of the rising prevalence of chromosome disorders, the surging maternal age, and rapid advancements in the healthcare industry across the world.